Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Diabetes Therapy
Adherence with therapy poor for working adults with type 2 diabetes
October 23rd, 2005
The adherence with pharmacotherapy was poor for newly diagnosed working adults with type 2 diabetes. According to recent research from the United States, "Trials have shown that intensive therapy to control blood glucose levels results in lower rates of microvascular complications and myocardial infarction among patients with type 2 diabetes. They have also demonstrated the economic and quality-of-life benefits of improved glycemic control among this patient population. Glycemic control achievable in controlled settings, however, may differ from that observed in actual practice settings, in part due to the patient's autonomy in determining whether, or to what extent,...
Source: Medical Letter on the CDC & FDA (2005-10-23)
|
